Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis

被引:3
|
作者
Wu, Xianfeng [1 ,2 ]
Zhou, Lei [3 ]
Zhan, Xiaojiang [4 ]
Wen, Yueqiang [5 ]
Wang, Xiaoyang [6 ]
Feng, Xiaoran [7 ]
Wang, Niansong [1 ,2 ]
Peng, Fenfen [8 ]
Wu, Junnan [9 ]
机构
[1] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Nephrol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Peoples Hosp 6, Clin Res Ctr Chron Kidney Dis, Shanghai, Peoples R China
[3] Evergreen Tree Nephrol Assoc, Guangzhou, Peoples R China
[4] Nanchang Univ, Affiliated Hosp 1, Dept Nephrol, Nanchang, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 2, Dept Nephrol, Guangzhou, Peoples R China
[6] Zhengzhou Univ, Affiliated Hosp 1, Dept Nephrol, Zhengzhou, Peoples R China
[7] Jiujiang 1 Peoples Hosp, Dept Nephrol, Jiujiang, Peoples R China
[8] Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Guangzhou, Peoples R China
[9] Zhejiang Univ, Affiliated Sir Run Run Shaw Hosp, Med Coll, Dept Nephrol, Hangzhou, Peoples R China
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
关键词
peritoneal dialysis; mortality; low-density lipoprotein cholesterol (LDL-C); nutrition-clinical; cardiovascular mortality; CHRONIC KIDNEY-DISEASE; LDL CHOLESTEROL; EFFICACY; RISK; PARTICIPANTS; METAANALYSIS; ASSOCIATION; SAFETY; LEVEL; HEART;
D O I
10.3389/fnut.2022.910348
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BackgroundIn dialysis patients, lowering low-density lipoprotein cholesterol (LDL-C) did not provide benefits, which seemed implausible in clinical practice. We hypothesized a U-shaped association between LDL-C and mortality in dialysis patients. MethodsIn this multi-center retrospective real-world cohort study, 3,565 incident Chinese peritoneal dialysis (PD) patients between January 1, 2005, and May 31, 2020, were included. The associations between baseline LDL-C and mortality were examined using cause-specific hazard models. ResultsOf 3,565 patients, 820 died, including 415 cardiovascular deaths. As compared with the reference range (2.26-2.60 mmol/L), both higher levels of LDL-C (> 2.60 mmol/L) and lower levels of LDL-C (< 2.26 mmol/L) were associated with increased risks of all-cause mortality (hazard ratio [HR],1.35, 95% confidence index [CI], 1.09-1.66; HR 1.36, 95%CI, 1.13-1.64) and cardiovascular mortality (HR, 1.31, 95% CI, 1.10-1.72; HR, 1.64; 95% CI, 1.22-2.19). Malnutrition (albumin < 36.0 g/L) modified the association between LDL-C and cardiovascular mortality (P for interaction = 0.01). A significantly increased risk of cardiovascular mortality was observed among patients with malnutrition and lower levels of LDL-C (HR 2.96, 95%CI 1.43-6.12) or higher levels of LDL-C (HR 2.81, 95%CI 1.38-5.72). ConclusionLow and high levels of LDL-C at the start of PD procedure were associated with increased all-cause and cardiovascular mortality risks. Malnutrition may modify the association of LDL-C with cardiovascular mortality.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] LOW-DENSITY LIPOPROTEIN CHOLESTEROL (CLDL) AND LIPOPROTEIN PHENOTYPING
    MONAHAN, LK
    OKELL, RT
    ELLIOTT, JR
    [J]. AMERICAN JOURNAL OF MEDICAL TECHNOLOGY, 1975, 41 (08): : 307 - 309
  • [22] Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol
    Yeang, Calvin
    Karwatowska-Prokopczuk, Ewa
    Su, Fei
    Dinh, Brian
    Xia, Shuting
    Witztum, Joseph L.
    Tsimikas, Sotirios
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (11) : 1035 - 1046
  • [23] Fenofibrate lowers small low-density lipoprotein with no change in total low-density lipoprotein cholesterol
    Superko, HR
    Madan, S
    Tonnemacher, D
    Chronos, N
    Garrett, B
    Sheehan, D
    Raul, E
    Frohwein, S
    McGrath, K
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 316A - 316A
  • [24] Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol
    deGoma, Emil M.
    Leeper, Nicholas J.
    Heidenreich, Paul A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 49 - 55
  • [25] Low low-density lipoprotein cholesterol and cancer risk
    Strandberg, Timo E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 91 - 92
  • [26] Reliability of Calculated Low-Density Lipoprotein Cholesterol
    Meeusen, Jeffrey W.
    Snozek, Christine L.
    Baumann, Nikola A.
    Jaffe, Allan S.
    Saenger, Amy K.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (04): : 538 - 540
  • [27] Alirocumab for low-density lipoprotein cholesterol lowering
    Roth, Eli M.
    [J]. FUTURE CARDIOLOGY, 2019, 15 (01) : 17 - 29
  • [28] Statins and low-density lipoprotein cholesterol levels
    Cohen, JS
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01): : 74 - 75
  • [29] Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol
    Zheng, Weili
    Chilazi, Michael
    Park, Jihwan
    Sathiyakumar, Vasanth
    Donato, Leslie J.
    Meeusen, Jeffrey W.
    Lazo, Mariana
    Guallar, Eliseo
    Kulkarni, Krishnaji R.
    Jaffe, Allan S.
    Santos, Raul D.
    Toth, Peter P.
    Jones, Steven R.
    Martin, Seth S.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (02):
  • [30] LOW-DENSITY LIPOPROTEIN, LIVER AND CHOLESTEROL TRANSPORT
    SNIDERMAN, A
    TENG, B
    MARPOLE, D
    TANSER, P
    JERRY, M
    [J]. CLINICAL RESEARCH, 1975, 23 (03): : A333 - A333